
Affordable Diabetes Treatment Takes a Leap: FDA Approves Generic Liraglutide
The first generic version of the daily injectable diabetes drug liraglutide has been approved by the FDA. This innovation may provide a less expensive substitute for name-brand medications like Victoza, resolving persistent shortages and facilitating patient access to therapy. Many patients are struggling financially due to the escalating expense of diabetic medicines, but a recent…